TLR3 and neoplasm: Importantly, combined TLR3/CD40 stimulation was needed to increase the frequency of CD8+ TILs in AT-3 tumors, and tumor-specific Tet+ CD8+ T cells in the PB and 4T1 tumors (Fig. 4c).